Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Job J.M.H. van Bragt"'
Autor:
Stefania Principe, Levi B. Richards, Simone Hashimoto, Johannes Anthon Kroes, Job J.M.H. Van Bragt, Susanne J. Vijverberg, Jacob K. Sont, Nicola Scichilone, Kristina Bieksiene, Anneke Ten Brinke, Zsuzsanna Csoma, Barbro Dahlén, Bilun Gemicioglu, Ineta Grisle, Piotr Kuna, Zorica Lazic, Florin Mihaltan, Sanja Popović-Grle, Sabina Škrgat, Alessandro Marcon, Marco Caminati, Ratko Djukanovic, Celeste Porsbjerg, Anke-Hilse Maitland Van Der Zee
Publikováno v:
ERJ Open Research, Vol 9, Iss 3 (2023)
Background The use of anti-interleukin-5 (IL5) for severe asthma is based on criteria from randomised controlled trials (RCTs), but in real-life patients might not fulfil the eligibility criteria but may benefit from biologics. We aimed to characteri
Externí odkaz:
https://doaj.org/article/352cbfdad2894a888d1e292ee4777930
Autor:
Job J.M.H. van Bragt, Susanne Hansen, Ratko Djukanovic, Elisabeth H.D. Bel, Anneke ten Brinke, Scott S. Wagers, Anke H. Maitland-van der Zee, Celeste Porsbjerg
Publikováno v:
ERJ Open Research, Vol 7, Iss 2 (2021)
Real-world evidence is important to help unravel unanswered problems in severe asthma and is valuable to better understand the patient experience and common clinical practice. The Severe Heterogeneous Asthma Registry, Patient-centred (SHARP) Clinical
Externí odkaz:
https://doaj.org/article/26a34a22cbef4c7abcbbda697a53dd3d
Autor:
Job J.M.H. van Bragt, Paul Brinkman, Rianne de Vries, Susanne J.H. Vijverberg, Els J.M. Weersink, Eric G. Haarman, Frans H.C. de Jongh, Sigrid Kester, Annelies Lucas, Johannes C.C.M. in 't Veen, Peter J. Sterk, Elisabeth H.D. Bel, Anke H. Maitland-van der Zee
Publikováno v:
ERJ Open Research, Vol 6, Iss 4 (2020)
Molecular profiling of exhaled breath by electronic nose (eNose) might be suitable as a noninvasive tool that can help in monitoring of clinically unstable COPD patients. However, supporting data are still lacking. Therefore, as a first step, this st
Externí odkaz:
https://doaj.org/article/c7ce607d47cb4c43b5ee15e6c9274687
Autor:
Stefania Principe, Job J.M.H. van Bragt, Cristina Longo, Rianne de Vries, Peter J. Sterk, Nicola Scichilone, Susanne J.H. Vijverberg, Anke H. Maitland-van der Zee
Publikováno v:
Molecules, Vol 26, Iss 5, p 1357 (2021)
Breath analysis using eNose technology can be used to discriminate between asthma and COPD patients, but it remains unclear whether results are influenced by smoking status. We aim to study whether eNose can discriminate between ever- vs. never-smoke
Externí odkaz:
https://doaj.org/article/f11d629bbae8486cb7212428363fe037
Autor:
Josien Smits, Marleen Kemper, Jessy Van Wezenbeek, Wim Boersma, Patrick J Smeele, Lucas R Celant, Erik Duijvelaar, Wouter Hoefsloot, Pierre M Bet, Leo M. A. Heunks, M.J. Overbeek, Anton Vonk Noordegraaf, Carol Pamplona, Marry R. Smit, Laurien M.A. Oswald, Ary Serpa Neto, Jurjan Aman, Herman M.A. Hofstee, Job R Schippers, Katrien Eger, Ivo van der Lee, Janneke E Stalenhoef, Miranda Geelhoed, Arthur L E M Vanhove, Nienke Paternotte, Karin A. Boomars, Azar Kianzad, Frank W.J.M. Smeenk, Esther J. Nossent, Adinda Mieras, Elise M A Slob, Jeroen N. Wessels, Michel M. van den Heuvel, Yurika L E van Glabbeek, Chris Happé, Renate Kos, Anke-Hilse Maitland-van der Zee, Nicole P. Juffermans, Laurien Van Der Lee, Imke H Bartelink, Pieter R. Tuinman, Gert-Jan Braunstahl, Peter W.A. Kunst, Marcus J. Schultz, Laura A. Hagens, Romke Hoekstra, Niels Pronk, Lieuwe D. J. Bos, Frances Handoko-De Man, Hans P. Grotjohan, Sara Azhang, Michiel Alexander de Raaf, Liza Botros, Peter I. Bonta, Pearl Mau-Asam, Rianne J A Hoek, Harm Jan Bogaard, Job J.M.H. van Bragt, Marije Lammers
Publikováno v:
Aman, J, Duijvelaar, E, Botros, L, Kianzad, A, Schippers, J, Smeele, P, Azhang, S, Bartelink, I, Bet, P, Boersma, W, Boomars, K, Bonta, P, Bos, L, Van Bragt, J, Braunstahl, G-J, Celant, L, Eger, K, Geelhoed, M, Van Glabbeek, Y, Grotjohan, H, Hagens, L, Happe, C, Heunks, L, Van Den Heuvel, M, Hoefsloot, W, Hoek, R, Hoekstra, R, Hofstee, H, Vanhove, A, Juffermans, N, Lammers, M, Kos, R, Kemper, M, Kunst, P, Van Der Lee, I, Van Der Lee, L, Mau-Asam, P, Maitland-Van Der Zee, A-H, Mieras, A, Nossent, E, Overbeek, M, Oswald, L, Paternotte, N, Pamplona, C, Pronk, N, De Raaf, M, Slob, E, Neto, A S, Schultz, M, Smit, M, Smeenk, F, Smits, J, Stalenhoef, J, Tuinman, P R, Wessels, J, Van Wezenbeek, J, Noordegraaf, A V, Handoko-De Man, F & Bogaard, H J 2021, ' Late Breaking Abstract-A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19 ', European Respiratory Journal, vol. 58 . https://doi.org/10.1183/13993003.congress-2021.OA4119
European Respiratory Journal
Airway cell biology and immunopathology
European Respiratory Journal, 58. European Respiratory Society
European Respiratory Journal
Airway cell biology and immunopathology
European Respiratory Journal, 58. European Respiratory Society
Autor:
Job J.M.H. van Bragt, Michiel Alexander de Raaf, Harm Jan Bogaard, Pierre M Bet, Azar Kianzad, Merlijn Reijrink, Esther J. Nossent, Job R Schippers, Lucas R Celant, Lieuwe D. J. Bos, Jeroen N. Wessels, Mirte Muller, Chris Happé, Niels Pronk, Anton Vonk Noordegraaf, Leo M. A. Heunks, Liza Botros, E Marleen Kemper, Wim Boersma, Michel van den Heuvel, Hans P Grotjohan, Rianne J A Hoek, Carolina C Pamplona, Sara Azhang, Nicole P. Juffermans, Marry R Smit, Ivo van der Lee, Imke H Bartelink, Bas F M van Raaij, Janneke E Stalenhoef, Wouter Hoefsloot, Pieter R. Tuinman, Ariana Lammers, Katrien Eger, Boaz D Hazes, E Laurien van der Lee, Karin A T Boomars, Arthur L E M Vanhove, Frances S. de Man, Laura A Hagens, Anke-Hilse Maitland-van der Zee, Elisabeth C W Neefjes, Marcus J. Schultz, Pearl F M Mau Asam, Erik Duijvelaar, Patrick J Smeele, A. Josien Smits, Frank W J M Smeenk, Elise M A Slob, Laurien M A Oswald, Ary Serpa Neto, J. J. Miranda Geelhoed, Jessie Van Wezenbeek, Gert-Jan Braunstahl, Herman M A Hofstee, Romke Hoekstra, Peter I. Bonta, Jurjan Aman, Nienke Paternotte, Renate Kos, Ahmed A. Bayoumy, Peter W A Kunst, Maria J Overbeek, Adinda Mieras, Yurika L E van Glabbeek
Publikováno v:
lancet. Respiratory medicine, 9(9), 957-968. Elsevier Limited
The Lancet Respiratory Medicine, 9(9), 957-968. ELSEVIER SCI LTD
The Lancet Respiratory Medicine, 9(9), 957-968. Elsevier Ltd.
Lancet Respiratory Medicine, 9, 957-968
Aman, J, Duijvelaar, E, Botros, L, Kianzad, A, Schippers, J R, Smeele, P J, Azhang, S, Bartelink, I H, Bayoumy, A A, Bet, P M, Boersma, W, Bonta, P I, Boomars, K A T, Bos, L D J, van Bragt, J J M H, Braunstahl, G-J, Celant, L R, Eger, K A B, Geelhoed, J J M, van Glabbeek, Y L E, Grotjohan, H P, Hagens, L A, Happe, C M, Hazes, B D, Heunks, L M A, van den Heuvel, M, Hoefsloot, W, Hoek, R J A, Hoekstra, R, Hofstee, H M A, Juffermans, N P, Kemper, E M, Kos, R, Kunst, P W A, Lammers, A, van der Lee, I, van der Lee, E L, Maitland-van der Zee, A-H, Mau Asam, P F M, Mieras, A, Muller, M, Neefjes, L, Nossent, E J, Oswald, L M A, Overbeek, M J, Pamplona, C, Paternotte, N, Pronk, N, de Raaf, M A, van Raaij, B F M, Reijrink, M, Schultz, M J, Serpa Neto, A, Slob, E M, Smeenk, F W J M, Smit, M R, Smits, A J, Stalenhoef, J E, Tuinman, P R, Vanhove, A L E M, Wessels, J N, van Wezenbeek, J C C, Vonk Noordegraaf, A, de Man, F S & Bogaard, H J 2021, ' Imatinib in patients with severe COVID-19 : a randomised, double-blind, placebo-controlled, clinical trial ', Lancet respiratory medicine, vol. 9, no. 9, pp. 957-968 . https://doi.org/10.1016/S2213-2600(21)00237-X
The Lancet. Respiratory Medicine
Lancet respiratory medicine, 9(9), 957-968. Elsevier Limited
Lancet Respiratory Medicine, 9, 9, pp. 957-968
The Lancet Respiratory Medicine
The Lancet Respiratory Medicine, 9(9), 957-968. ELSEVIER SCI LTD
The Lancet Respiratory Medicine, 9(9), 957-968. Elsevier Ltd.
Lancet Respiratory Medicine, 9, 957-968
Aman, J, Duijvelaar, E, Botros, L, Kianzad, A, Schippers, J R, Smeele, P J, Azhang, S, Bartelink, I H, Bayoumy, A A, Bet, P M, Boersma, W, Bonta, P I, Boomars, K A T, Bos, L D J, van Bragt, J J M H, Braunstahl, G-J, Celant, L R, Eger, K A B, Geelhoed, J J M, van Glabbeek, Y L E, Grotjohan, H P, Hagens, L A, Happe, C M, Hazes, B D, Heunks, L M A, van den Heuvel, M, Hoefsloot, W, Hoek, R J A, Hoekstra, R, Hofstee, H M A, Juffermans, N P, Kemper, E M, Kos, R, Kunst, P W A, Lammers, A, van der Lee, I, van der Lee, E L, Maitland-van der Zee, A-H, Mau Asam, P F M, Mieras, A, Muller, M, Neefjes, L, Nossent, E J, Oswald, L M A, Overbeek, M J, Pamplona, C, Paternotte, N, Pronk, N, de Raaf, M A, van Raaij, B F M, Reijrink, M, Schultz, M J, Serpa Neto, A, Slob, E M, Smeenk, F W J M, Smit, M R, Smits, A J, Stalenhoef, J E, Tuinman, P R, Vanhove, A L E M, Wessels, J N, van Wezenbeek, J C C, Vonk Noordegraaf, A, de Man, F S & Bogaard, H J 2021, ' Imatinib in patients with severe COVID-19 : a randomised, double-blind, placebo-controlled, clinical trial ', Lancet respiratory medicine, vol. 9, no. 9, pp. 957-968 . https://doi.org/10.1016/S2213-2600(21)00237-X
The Lancet. Respiratory Medicine
Lancet respiratory medicine, 9(9), 957-968. Elsevier Limited
Lancet Respiratory Medicine, 9, 9, pp. 957-968
The Lancet Respiratory Medicine
Background The major complication of COVID-19 is hypoxaemic respiratory failure from capillary leak and alveolar oedema. Experimental and early clinical data suggest that the tyrosine-kinase inhibitor imatinib reverses pulmonary capillary leak. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95b9388602de3565960dbc68949c8a0a
https://pure.amc.nl/en/publications/imatinib-in-patients-with-severe-covid19(40a385b0-de53-45cd-aff2-cb6b5cdfc6d3).html
https://pure.amc.nl/en/publications/imatinib-in-patients-with-severe-covid19(40a385b0-de53-45cd-aff2-cb6b5cdfc6d3).html
Autor:
Stefania Principe, Celeste Porsbjerg, Job J.M.H. van Bragt, Nanna Dyhre-Petersen, Yoni E van Dijk, Christopher E. Brightling, Anke H. Maitland-van der Zee, Sven-Erik Dahlén, Korneliusz Golebski, Ditte Kjærsgaard Klein, Lente L H Dankelman, Susanne J. H. Vijverberg, Sisse B. Ditlev
Publikováno v:
Principe, S, Porsbjerg, C, Bolm Ditlev, S, Kjærsgaard Klein, D, Golebski, K, Dyhre-petersen, N, Dijk, Y E, Bragt, J J M H, Dankelman, L L H, Dahlen, S, Brightling, C E, Vijverberg, S J H & Maitland-van Der Zee, A H 2021, ' Treating severe asthma : Targeting the IL-5 pathway ', Clinical and Experimental Allergy, vol. 51, no. 8, pp. 992-1005 . https://doi.org/10.1111/cea.13885
Clinical and Experimental Allergy
Clinical and Experimental Allergy
Severe asthma is a heterogeneous disease with different phenotypes based on clinical, functional or inflammatory parameters. In particular, the eosinophilic phenotype is associated with type 2 inflammation and increased levels of interleukin (IL)‐4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d2ed7cd07e01ccaf516453e0ffb86c9
https://curis.ku.dk/portal/da/publications/treating-severe-asthma(8503ce7e-daca-4ebd-8233-399ea312fef2).html
https://curis.ku.dk/portal/da/publications/treating-severe-asthma(8503ce7e-daca-4ebd-8233-399ea312fef2).html
Autor:
Peter J. Sterk, Cristina Longo, Job J.M.H. van Bragt, Anke H. Maitland-van der Zee, Nicola Scichilone, Rianne de Vries, Susanne J. H. Vijverberg, Stefania Principe
Publikováno v:
Molecules, Vol 26, Iss 1357, p 1357 (2021)
Molecules, 26(5):1357. Multidisciplinary Digital Publishing Institute
Molecules
Volume 26
Issue 5
Molecules, 26(5):1357. Multidisciplinary Digital Publishing Institute
Molecules
Volume 26
Issue 5
Breath analysis using eNose technology can be used to discriminate between asthma and COPD patients, but it remains unclear whether results are influenced by smoking status. We aim to study whether eNose can discriminate between ever- vs. never-smoke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad4030d1b6fabf0e21b7eddaecda93df
http://hdl.handle.net/10447/550163
http://hdl.handle.net/10447/550163
Autor:
Anneke ten Brinke, Elisabeth H. Bel, Job J.M.H. van Bragt, Anke-Hilse Maitland-van der Zee, Gert-Jan Braunstahl, Cristina Longo, Reim Aarab, Els J.M. Weersink, J. K. Sont, Levi B. Richards, Anne H. Neerincx
Publikováno v:
Journal of Allergy and Clinical Immunology: In Practice, 8(9), 2999-3008.e1
Journal of Allergy and Clinical Immunology: In Practice, 8(9), 2999-+. ELSEVIER
Journal of Allergy and Clinical Immunology: In Practice, 8(9), 2999-+. ELSEVIER
BACKGROUND: Patients with severe asthma not meeting the strict trial eligibility criteria for mepolizumab are now routinely treated with this biological in clinical practice, but it remains unclear whether these ineligible patients respond differentl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f0f7a33b9cfd59e091e53b0e2b7075c
https://hdl.handle.net/1887/3185078
https://hdl.handle.net/1887/3185078
Autor:
Eric G. Haarman, Annelies Lucas, Paul Brinkman, Job J.M.H. van Bragt, Els J.M. Weersink, Sigrid Kester, Elisabeth H. Bel, Frans H.C. de Jongh, Johannes C C M In 't Veen, Rianne de Vries, Susanne J. H. Vijverberg, Anke H. Maitland-van der Zee, Peter J. Sterk
Publikováno v:
van Bragt, J J M H, Brinkman, P, de Vries, R, Vijverberg, S J H, Weersink, E J M, Haarman, E G, de Jongh, F H C, Kester, S, Lucas, A, In 't Veen, J C C M, Sterk, P J, Bel, E H D & Maitland-van der Zee, A H 2020, ' Identification of recent exacerbations in COPD patients by electronic nose ', BMJ Open, vol. 6, no. 4, 00307 . https://doi.org/10.1183/23120541.00307-2020
ERJ Open Research
article-version (VoR) Version of Record
ERJ open research, 6(4):00307-2020. European Respiratory Society
ERJ Open Research, 6(4):00307-2020. European Respiratory Society
BMJ Open, 6(4):00307. BMJ Publishing Group
ERJ Open Research, Vol 6, Iss 4 (2020)
ERJ Open Research
article-version (VoR) Version of Record
ERJ open research, 6(4):00307-2020. European Respiratory Society
ERJ Open Research, 6(4):00307-2020. European Respiratory Society
BMJ Open, 6(4):00307. BMJ Publishing Group
ERJ Open Research, Vol 6, Iss 4 (2020)
Molecular profiling of exhaled breath by electronic nose (eNose) might be suitable as a noninvasive tool that can help in monitoring of clinically unstable COPD patients. However, supporting data are still lacking. Therefore, as a first step, this st